Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sperm acrosome associated 7 (SPACA7) is a novel, testis-specific protein that localizes to the acrosome of elongating spermatids and mature spermatozoa[1]. It lacks homology to any known protein family and is conserved in mammals like mice and humans[1]. Expression of SPACA7 begins in mid-late spermatocyte stages, increases in round spermatids, and remains high through the maturation of sperm[1]. It is retained within the acrosome and is released during the acrosome reaction, a process essential for fertilization[1]. Functional studies using antibodies demonstrate that SPACA7 promotes dispersal of cumulus cells surrounding the egg and assists in fertilization, although the precise molecular mechanism remains unknown[1]. There are currently no drugs or known inhibitors targeting SPACA7, and no established disease associations or safety concerns related to therapeutic interventions[1].\nSPACA7 is not considered a traditional therapeutic target (such as a receptor, enzyme, transporter, or ion channel), but is a specific component of sperm implicated in fertilization processes[1].
Not applicable (no drugs known to act on SPACA7)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sperm acrosome associated 7 (SPACA7).